Elevation Point Wealth Partners LLC Makes New $2.52 Million Investment in CME Group Inc. $CME

Elevation Point Wealth Partners LLC bought a new stake in shares of CME Group Inc. (NASDAQ:CME) in the second quarter, Holdings Channel reports. The fund bought 11,389 shares of the financial services provider’s stock, valued at approximately $2,515,000.

Several other large investors have also recently made changes to their positions in the business. Northwestern Mutual Investment Management Company LLC boosted its position in shares of CME Group by 0.3% in the 4th quarter. Northwestern Mutual Investment Management Company LLC now owns 11,523 shares of the financial services provider’s stock worth $3,147,000 after purchasing an additional 37 shares in the last quarter. Rehmann Capital Advisory Group increased its position in CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after buying an additional 37 shares in the last quarter. Endowment Wealth Management Inc. raised its stake in CME Group by 4.4% during the fourth quarter. Endowment Wealth Management Inc. now owns 895 shares of the financial services provider’s stock valued at $244,000 after buying an additional 38 shares during the last quarter. NBT Bank N A NY raised its stake in CME Group by 2.3% during the first quarter. NBT Bank N A NY now owns 1,666 shares of the financial services provider’s stock valued at $492,000 after buying an additional 38 shares during the last quarter. Finally, Resonant Capital Advisors LLC boosted its holdings in CME Group by 3.8% in the first quarter. Resonant Capital Advisors LLC now owns 1,073 shares of the financial services provider’s stock worth $317,000 after acquiring an additional 39 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Performance

Shares of NASDAQ:CME opened at $274.98 on Monday. The company has a market cap of $98.88 billion, a P/E ratio of 23.32, a PEG ratio of 3.27 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1 year low of $218.31 and a 1 year high of $329.16. The stock’s fifty day moving average price is $251.17 and its 200-day moving average price is $279.57.

CME Group (NASDAQ:CME) last released its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping the consensus estimate of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period last year, the company earned $2.96 EPS. CME Group’s revenue for the quarter was up .8% on a year-over-year basis. Sell-side analysts expect that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 44.11%.

Insider Activity at CME Group

In related news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction dated Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the completion of the acquisition, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.30% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on CME shares. Bank of America increased their target price on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. Keefe, Bruyette & Woods raised CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a research report on Thursday, June 18th. Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and upped their price target for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Raymond James Financial reissued an “outperform” rating and set a $320.00 price objective on shares of CME Group in a research report on Thursday, July 2nd. Finally, UBS Group reduced their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research note on Monday, July 6th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.